Lysteda and Zyrtec drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lysteda (tranexamic acid) and Zyrtec (cetirizine hydrochloride). Common drug interactions include middle insomnia among females and conjunctivitis allergic among males.

The phase IV clinical study analyzes what interactions people have when they take Lysteda and Zyrtec. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Lysteda?

Lysteda has active ingredients of tranexamic acid. It is often used in menstrual periods - heavy, prolonged, or irregular. eHealthMe is studying from 289 Lysteda users. Check the latest studies of Lysteda.

What is Zyrtec?

Zyrtec has active ingredients of cetirizine hydrochloride. It is often used in allergies. eHealthMe is studying from 114,620 Zyrtec users. Check the latest studies of Zyrtec.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 22, 2026

15 people who take Lysteda and Zyrtec together, and have interactions are studied.

Lysteda and Zyrtec drug interactions.

What are the common drug interactions of Lysteda and Zyrtec, by gender? *:

female:

  1. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
  2. Poor quality sleep
  3. Retching (strong involuntary effort to vomit)
  4. Choking sensation (feeling of obstruction in respiratory system)
  5. Cholecystitis acute (rapid infection of gallbladder)
  6. Cholecystitis infective (infection of gallbladder capable to infect other organs)
  7. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  8. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  9. Conversion disorder (neurological symptoms, such as numbness, blindness, paralysis, or fits without a definable organic cause)
  10. Dysgraphia (impaired ability to learn to write)

male:

  1. Conjunctivitis allergic (inflammation of the conjunctiva due to allergy)
  2. Eye irritation
  3. Eye pain
  4. Eye pruritus (eye itching)
  5. Eye swelling
  6. Lacrimation increased

What are the common drug interactions of Lysteda and Zyrtec, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Drug ineffective
  2. Hunger
  3. Initial insomnia (feeling of inadequate or poor-quality sleep)
  4. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
  5. Poor quality sleep
  6. Retching (strong involuntary effort to vomit)

30-39:

  1. Conjunctivitis allergic (inflammation of the conjunctiva due to allergy)
  2. Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
  3. Pain
  4. Plantar fasciitis (painful inflammatory process of the plantar fascia)
  5. Procedural haemorrhage (procedural bleeding)
  6. Urinary tract infection
  7. Uterine perforation (accidental puncture of the uterus)
  8. Vomiting
  9. Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
  10. Eye irritation

40-49:

n/a

50-59:

  1. Hereditary angioedema (recurrent episodes of severe swelling)

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 53.33%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 46.67%
  3. Cystic Fibrosis (disease of the secretary glands): 3 people, 20.00%
  4. Vitamin B Complex Deficiency: 1 person, 6.67%
  5. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 6.67%
  6. Allergy To Plants: 1 person, 6.67%
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 6.67%
  8. Asthma: 1 person, 6.67%
  9. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 6.67%
  10. Birth Control: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Lysteda and Zyrtec?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lysteda and Zyrtec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lysteda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zyrtec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lysteda and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zyrtec and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tranexamic acid and cetirizine hydrochloride (the active ingredients of Lysteda and Zyrtec, respectively), and Lysteda and Zyrtec (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: